Journal
MEDICINAL RESEARCH REVIEWS
Volume 38, Issue 6, Pages 1799-1836Publisher
WILEY
DOI: 10.1002/med.21497
Keywords
antibodies; carbonic anhydrase IX; diagnostic tools; drugs; hypoxic tumors; small molecule inhibitors
Categories
Funding
- CNR-DSB ProgettoBandiera InterOmics
- CNR-DSB
Ask authors/readers for more resources
Human carbonic anhydrase (CA) IX is a tumor-associated protein, since it is scarcely present in normal tissues, but highly overexpressed in a large number of solid tumors, where it actively contributes to survival and metastatic spread of tumor cells. Due to these features, the characterization of its biochemical, structural, and functional features for drug design purposes has been extensively carried out, with consequent development of several highly selective small molecule inhibitors and monoclonal antibodies to be used for different purposes. Aim of this review is to provide a comprehensive state-of-the-art of studies performed on this enzyme, regarding structural, functional, and biomedical aspects, as well as the development of molecules with diagnostic and therapeutic applications for cancer treatment. A brief description of additional pharmacologic applications for CA IX inhibition in other diseases, such as arthritis and ischemia, is also provided.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available